Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Delk
Edward Delk, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090076980 | METHOD OF ADMINISTERING A MUTUAL FUND THAT SEEKS TO PROVIDE REGULAR MONTHLY PAYMENTS WITHOUT CONSUMING PRINCIPAL - A method of administering an investment fund. The method includes the steps of creating shares for sale, providing a managed distribution schedule identifying a number of payments to be provided during each of consecutive periods, providing an investment strategy for investing in assets to provide funds sufficient to meet the managed distribution schedule, issuing a share to an investor in exchange for funds received from the investor, investing the received funds according to the investment strategy, calculating the value of each of the payments to be provided according to the managed distribution schedule in a period to the investor, and providing each of the payments to the investor during the period. Each payment is calculated according to a formula that specifies that the value of each payment is based on a trailing Net Asset Value (NAV) of the investor's share. | 03-19-2009 |
Karen Delk, Cedar Park, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20090251173 | SINGLE-SUPPLY, SINGLE-ENDED LEVEL CONVERSION CIRCUIT FOR AN INTEGRATED CIRCUIT HAVING MULTIPLE POWER SUPPLY DOMAINS - A circuit comprises first, second, third, and fourth transistors. The first transistor has a first current electrode, a control electrode for receiving an input signal, and a second current electrode. The second transistor has a first current electrode coupled to the second current electrode of the first transistor for providing an output signal, a control electrode coupled to the control electrode of the first transistor, and a second current electrode coupled to a first power supply voltage terminal. The third transistor has a first current electrode coupled to a second power supply voltage terminal, a control electrode, and a second current electrode coupled to the first current electrode of the first transistor. The fourth transistor has a first current electrode coupled to the control electrode of the third transistor, a control electrode coupled to the control electrodes of the first and second transistors, and a second current electrode coupled to the control electrode of the first transistor. | 10-08-2009 |
Louis D. Delk, Phoenix, AZ US
| Patent application number | Description | Published |
|---|---|---|
| 20100138259 | SERVICE MANAGEMENT SYSTEMS AND ASSOCIATED METHODS - Service management systems and associated methods are disclosed herein. In one embodiment, a service management system can include a system for delivering various types of services including property management services, residential rental services, social services, low income housing services, and/or the like. One aspect of the disclosure is directed toward a computer implemented service management process (e.g., a property management process) that includes maintaining an inventory of property associated with a rental program, providing information associated with the rental program, processing an application to enter the program from a potential program participant, and administering various program elements of the rental program. In selected embodiments, the method can further include providing products/services and/or providing advertising. In still further embodiments, the method can include terminating the program participant's participation in the rental program/service management process. | 06-03-2010 |
Nikki Delk, Houston, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20120114636 | LOW MOLECULAR WEIGHT CYCLIN E (LMW-E) AS A BIOMARKER FOR PERSONALIZATION OF CANCER THERAPIES - Methods are disclosed for predicting a patient response to anti-Her2 therapy or anti-aromatase therapy. In certain embodiments, the methods involve the identification of low molecular weight cyclin E (LMW-E) in cancers, such as breast cancer cells, as a predictive and prognostic marker. In further embodiments, LMW-E expression by a cancerous or pre-cancerous cell may be used to predict response to an aromatase inhibitor and/or CDK2 inhibitor, and determination of LMW-E expression may be used in the personalization of cancer therapies. | 05-10-2012 |